Helix BioPharma (TSE:HBP) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Helix BioPharma Corp. has appointed James B. Murphy as its new Chief Financial Officer, bringing his extensive experience in finance and operations management to the company. Murphy, a seasoned consultant in the life sciences industry, is expected to drive strategic growth and support Helix’s focus on advancing its CEACAM6 platform in oncology.
For further insights into TSE:HBP stock, check out TipRanks’ Stock Analysis page.